The White House’s plan to invest more than $5 billion in the development of next-generation COVID-19 vaccines could spur the creation of novel vaccine technologies for other viruses, including flu, as well as combination COVID-19 and flu vaccines, an infectious disease expert told Inside Health Policy . Republicans, however, want to claw back all of the funding for the White House initiative as part of their debt ceiling reduction bill, introduced April 19 and passed by the House Wednesday (April...